webinar "Evidence-based Treatment for Stimulant Use Disorder"

Register now at: https://thenationalcouncil-org.zoom.us/webinar/register/WN_j84WXmDCTMiJSxcrInGdhg#/registration

Tuesday, April 7, 2026, 13:00 ET (Washington, DC time)

Join the Providers Clinical Support System-Medications for Opioid Use Disorders and the National Council for Mental Wellbeing for the Evidence-based Treatment for Stimulant Use Disorder webinar on April 7, 1-2 p.m. ET. While exploring the growing impact of stimulant use and overdose in the U.S., this session will highlight practical, evidence-based strategies for organizations to effectively treat stimulant use disorder and improve patient outcomes. Stimulant use, including cocaine, methamphetamine and prescription stimulants, continues to be a growing and urgent public health concern. According to the 2024 National Survey on Drug Use and Health, 9 million people in the U.S. had used stimulants not as prescribed in the past year. Though opioids are often the focus of overdose conversations, stimulant-related overdose deaths reached an estimated 51,630 in 2024, while 59% of all overdoses from January 2021 through June 2024 involved a stimulant (Centers for Disease Control and Prevention, 2025). These trends underscore the critical need for effective treatment and engagement strategies. Several evidence-based behavioral therapies exist to help providers treat stimulant use disorder. This webinar will outline the clinical and administrative approaches to assess, treat and support people experiencing stimulant use disorder.

Educational objectives:

- Describe current trends in stimulant use and overdose in the U.S. and how this data informs clinical practice.

- Identify evidence-based treatments for stimulant use disorder, including behavioral interventions.

- Understand key administrative and clinical considerations for addressing stimulant use.

Featured speakers: Thomas E. Freese, PhD, Director, UCLA Integrated Substance Use and Addiction Programs